Peregrine Pharmaceuticals Inc. Product Market Growth 2015

1
Peregrine Pharmaceuticals, Inc. Product Pipeline
Review - 2015
Published on October - 2015
2
.
Report Overview
About Peregrine Pharmaceuticals, Inc. Product
Pipeline Review 2015 Global Markets Directs,
Peregrine Pharmaceuticals, Inc. Product Pipeline
Review - 2015, provides an overview of the
Peregrine Pharmaceuticals, Inc. s pharmaceutical
research and development focus. This report
provides comprehensive information on the current
therapeutic developmental pipeline of Peregrine
Pharmaceuticals, Inc. s, complete with
comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type. It also reviews latest
updates, and featured news and press releases,
along with special features on late-stage and
discontinued projects. Global Markets Directs
report features investigational drugs from across
globe covering over 20 therapy areas and nearly
3,000 indications. The report is built using data
and information sourced from Global Markets
Directs proprietary data bases,
Company/University websites, SEC filings,
investor presentations and featured press
releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Directs team. Get
Full Details On http//www.researchbeam.com/pere
grine-pharmaceuticals-inc-product-pipeline-review-
2015-market
3
.
Report Overview
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Scope The report provides
brief overview of Peregrine Pharmaceuticals, Inc.
including business description, key information
and facts, and its locations and subsidiaries The
report reviews current pipeline of Peregrine
Pharmaceuticals, Inc. s human therapeutic
division and enlists all their major and minor
projects
4
.
Report Overview
The report features product description and
descriptive mechanism of action for key pipeline
products along with the products developmental
history and major milestones Special feature on
out-licensed and partnered product portfolio The
report summarizes all the dormant and
discontinued pipeline projects Latest company
statement Latest news and deals relating to the
Peregrine Pharmaceuticals, Inc. spipeline
products   Reasons to buy Evaluate Peregrine
Pharmaceuticals, Inc. sstrategic position with
total access to detailed information on its
product pipeline Assess the growth potential of
Peregrine Pharmaceuticals, Inc. in its therapy
areas of focus Identify new drug targets and
therapeutic classes in the Peregrine
Pharmaceuticals, Inc. s RD portfolio and develop
key strategic initiatives to reinforce pipeline
in those areas Exploit in-licensing opportunities
by identifying windows of opportunity to fill
portfolio gaps
5
Report Overview

• Develop strategic initiatives by understanding
  the focus areas of Peregrine Pharmaceuticals,
  Inc. and exploit collaboration and partnership
  opportunities
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by
  identifying the most promising pipeline of
  Peregrine Pharmaceuticals, Inc.
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Explore the dormant and discontinued projects of
  Peregrine Pharmaceuticals, Inc. and identify
  potential opportunities in those areas
• Avoid Intellectual Property Rights related issues

6
Table Of Contents
List of Tables 4List of Figures 4Peregrine
Pharmaceuticals, Inc. Snapshot 5Peregrine
Pharmaceuticals, Inc. Overview 5Key Information
5Key Facts 5Peregrine Pharmaceuticals, Inc. -
Research and Development Overview 6Key
Therapeutic Areas 6Peregrine Pharmaceuticals,
Inc. - Pipeline Review 8Pipeline Products by
Stage of Development 8Pipeline Products -
Monotherapy 9Pipeline Products - Partnered
Products 10Partnered Products/Combination
Treatment Modalities 11Pipeline Products -
Out-Licensed Products 12
7
Table Of Contents
Out-Licensed Products/Combination Treatment
Modalities 13Peregrine Pharmaceuticals, Inc. -
Pipeline Products Glance 14Peregrine
Pharmaceuticals, Inc. - Late Stage Pipeline
Products 14Phase III Products/Combination
Treatment Modalities 14Peregrine
Pharmaceuticals, Inc. - Clinical Stage Pipeline
Products 15Phase II Products/Combination
Treatment Modalities 15Phase I
Products/Combination Treatment Modalities
16Peregrine Pharmaceuticals, Inc. - Early Stage
Pipeline Products 17Preclinical
Products/Combination Treatment Modalities
17Discovery Products/Combination Treatment
Modalities 18Peregrine Pharmaceuticals, Inc. -
Drug Profiles 19bavituximab 19 Product
Description 19Mechanism of Action 19
8
Table Of Contents
RD Progress 19iodine I 131 derlotuximab biotin
24Product Description 24Mechanism of Action
24RD Progress 24PGN-632 26Product Description
26Mechanism of Action 26RD Progress
26 Enquiry about this report _at_
http//www.researchbeam.com/peregrine-pharmaceutic
als-inc-product-pipeline-review-2015-market/enquir
e-about-report
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/peregrine-pharmaceutic
als-inc-product-pipeline-review-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] E-MAIL
sales_at_researchbeam.com